Medicine Image
Medicine Name:
IMBRUVICA
Generic Name:
Ibrutinib
Company Name:
JANSSEN BIOTECH
Packing:
140 mg Capsules in a bottle of 90 and 120 capsules
Enquiry:
Fill Form For Medicine Enquiry   

IMBRUVICA (Ibrutinib Capsules)

Description of Imbruvica 140 mg (Ibrutinib Capsules)
A Bruton’s Tyrosine Kinase Inhibitor (BTK)

Its use and Indications
Imbruvica (Ibrutinib) Capsules is indicated in the following:

*Mantle Cell Lymphoma

    • Treatment of patients with Mantle Cell Lymphoma (MCL) who have received at least one prior therapy

*Accelerated approval was granted for this indication based on overall response rate

Chronic Lymphocytic Leukemia

    • Treatment of patients with Chronic Lymphocytic Leukemia (CLL) who have received at least one prior therapy (see clinical studies)
    • Treatment of patients with Chronic Lymphocytic Leukemia (CLL) with 17p deletion (see clinical studies)

Waldenstrom’s Macroglobulinemia

      • Imbruvica is indicated for the patients with Waldenstrom’s Macroglobulinemia (WM)
      (see clinical studies)

Treatment
For treatment related information, please consult your treating Physician.

How Supplied

Imbruvica 140 mg Capsules in a bottle of 90 and 120 capsules

Storage and handling
Store at 20°- 25° C, excursions permitted to 15° to 30° C.

How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.

Company that Manufactures/ Markets:
M/s Janssen Biotec, Inc

Contact Details:
Mob No: +91 7738100125, +91 7738151650
E Mail: imports@specialitiespharma.com